Results 101 to 110 of about 55,137 (249)

Restenosis after percutaneous angioplasty: the role of vascular inflammation

open access: yesVascular Health and Risk Management, 2005
Martin Schillinger, Erich MinarDepartment of Angiology, University of Vienna Medical School, Vienna,AustriaAbstract: Restenosis after endovascular treatment of atherosclerotic lesions in the peripheral, cerebrovascular, and coronary circulation is the ...
Martin Schillinger, Erich Minar
doaj  

Electrophysiological effects of selective atrial coronary artery occlusion in humans [PDF]

open access: yes, 2016
Background-The arrhythmogenesis of ventricular myocardial ischemia has been extensively studied, but models of atrial ischemia in humans are lacking. This study aimed at describing the electrophysiological alterations induced by acute atrial ischemia ...
Cinca Cuscullola, Juan Maria   +6 more
core   +2 more sources

Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures [PDF]

open access: yes, 2007
Background To identify differences among men and women with acute coronary syndrome in terms of in-hospital mortality, and to assess whether these differences are related to the use of percutaneous cardiovascular procedures.
María J Aguado-Romeo   +3 more
core   +2 more sources

Percutaneous transluminal coronary angioplasty for the treatment of variant angina.

open access: yesJournal of the American College of Cardiology, 1985
Among 268 patients undergoing percutaneous transluminal coronary angioplasty between February 1980 and January 1983, a total of 21 patients had variant angina, documented before angioplasty in 14 and after angioplasty in 7.
Thierry Corcos   +6 more
semanticscholar   +1 more source

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions

open access: yesКардиоваскулярная терапия и профилактика, 2007
Coronary restenosis remains the main problem for effectiveness of percutaneous transluminal coronary angioplasty (PCA) and coronary stenting (CS). The aim of this review is to analyze pathogenetic mechanisms of coronary restenosis after PCA and CS, as ...
Yu. A. Shuvalova   +4 more
doaj  

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia

open access: yesActa Medica, 2017
To date, there are no sufficient data to make firm recommendations on the treatment of patients with severe thrombocytopenia who require antiplatelet therapy after experiencing acute coronary syndrome.
Francisco José Fernández-Fernández   +3 more
doaj   +1 more source

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. [PDF]

open access: yes, 2014
peer reviewedOBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease.
Alfonso, Fernando   +34 more
core   +4 more sources

Leave Nothing Behind in Coronary Intervention: Time to Move From Promise to Proof

open access: yes
Clinical Cardiology, Volume 48, Issue 12, December 2025.
Hasnain Wajeeh Saqib   +5 more
wiley   +1 more source

Stent placement for renal arterial stenosis: where do we stand? A meta-analysis [PDF]

open access: yes, 2000
PURPOSE: To perform a meta-analysis of renal arterial stent placement in comparison with renal percutaneous transluminal angioplasty (PTA) in patients with renal arterial stenosis.
Bosch, J.L. (Johanna)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy